DFBPID |
TPDPIV0029 |
ProteinName |
Dipeptidyl peptidase 4 |
Function |
Cell surface glycoprotein receptor involved in the
costimulatory signal essential for T-cell receptor (TCR)-mediated
T-cell activation. Acts as a positive regulator of T-cell coactivation,
by binding at least ADA, CAV1, IGF2R, and PTPRC. Its binding to CAV1 and
CARD11 induces T-cell proliferation and NF-kappa-B activation in a
T-cell receptor/CD3-dependent manner. Its interaction with ADA also
regulates lymphocyte-epithelial cell adhesion. In association with FAP
is involved in the pericellular proteolysis of the extracellular matrix
(ECM), the migration and invasion of endothelial cells into the ECM. May
be involved in the promotion of lymphatic endothelial cells adhesion,
migration and tube formation. When overexpressed, enhanced cell
proliferation, a process inhibited by GPC3. Acts also as a serine
exopeptidase with a dipeptidyl peptidase activity that regulates various
physiological processes by cleaving peptides in the circulation,
including many chemokines, mitogenic growth factors, neuropeptides and
peptide hormones. Removes N-terminal dipeptides sequentially from
polypeptides having unsubstituted N-termini provided that the
penultimate residue is proline. |
TargetGene |
Specific Target Gene | Target protein:
| Recommended name: • Dipeptidyl peptidase 4 (EC:3.4.14.5) Alternative name(s): • ADABP • Adenosine deaminase complexing protein 2 ▪ Short name: ADCP-2 • Dipeptidyl peptidase IV ▪ Short name: DPP IV • T-cell activation antigen CD26 • TP103 • CD_antigen: CD26 Cleaved into the following 2 chains: • Dipeptidyl peptidase 4 membrane form Alternative name(s): ▪ Dipeptidyl peptidase IV membrane form • Dipeptidyl peptidase 4 soluble form Alternative name(s): ▪ Dipeptidyl peptidase IV soluble form | Target gene ID:
| DPP4 | Organism of Target:
| Homo sapiens (Human)
| Taxonomic identifier:
| 9606 [NCBI] | Target Uniprot ID: | P27487 | Target ChEMBL ID:
| CHEMBL284 | Target TTD ID: | T31391 |
|
Diseases |
Diseases associated with this peptide | Autoimmune diabetes [ICD10: E08-E13] | Autism [ICD9: 299; ICD10: F84.0] | Bone marrow transplantation [ICD9: 279.5, 996; ICD10: D89.8, T86] | Diabetes [ICD9: 253.5, 588.1; ICD10: E23.2, N25.1] | Hematological malignancies [ICD9: 200-209; ICD10: C81-C86] | Hypoglycemia [ICD9: 250.8, 251.0, 251.1, 251.2, 270.3, 775.6, 962.3; ICD10: E16.0-E16.2] | Metabolic disorders [ICD9: 270-279; ICD10: E70-E89] | Non-insulin dependent diabetes [ICD10: E11.9] | Psoriasis [ICD9: 696; ICD10: L40] | Type 2 diabetes [ICD9: 250; ICD10: E11] | Unspecified [ICD code not available] |
|
Pathways |
Enzyme and pathway databases of target protein | BRENDA | 3.4.14.5 2681 | Reactome | R-HSA-381771 Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) R-HSA-400511 Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
|
|